Dataset Information


Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy.

ABSTRACT: Nanoparticle (NP)-based combination chemotherapy has been proposed as a potent strategy for enhancing intracellular drug concentrations and achieving synergistic effects in colon cancer therapy. Here, we fabricated a series of chitosan-functionalized camptothecin (CPT)/curcumin (CUR)-loaded polymeric NPs with various weight ratios of CPT to CUR. The resultant cationic spherical CPT/CUR-NPs had a desirable particle size (193-224 nm), relatively narrow size distribution, and slightly positive zeta-potential. These NPs exhibited a simultaneous sustained release profile for both drugs throughout the study period with a slight, initial burst release. Subsequent cellular uptake experiments demonstrated that the introduction of chitosan to the NP surface markedly increased cellular-uptake efficiency compared with other drug formulations, and thus increased the intracellular drug concentrations. Importantly, the combined delivery of CPT and CUR in a single NP enhanced synergistic effects of the two drugs. Among the five cationic CPT/CUR-NPs tested, NPs with a CPT/CUR weight ratio of 4:1 showed the highest anticancer activity, resulting in a combination index of approximately 0.46. In summary, our study represents the first report of combinational application of CPT and CUR with a one-step-fabricated co-delivery system for effective colon cancer combination chemotherapy.


PROVIDER: S-EPMC4662402 | BioStudies | 2015-01-01

REPOSITORIES: biostudies

Similar Datasets

2015-01-01 | S-EPMC4618760 | BioStudies
2015-01-01 | S-EPMC4339818 | BioStudies
1000-01-01 | S-EPMC6071138 | BioStudies
2018-01-01 | S-EPMC6222858 | BioStudies
2020-01-01 | S-EPMC7578901 | BioStudies
2020-01-01 | S-EPMC7507500 | BioStudies
1000-01-01 | S-EPMC4649518 | BioStudies
2020-01-01 | S-EPMC7795977 | BioStudies
2012-01-01 | S-EPMC3428249 | BioStudies
2021-01-01 | S-EPMC7915402 | BioStudies